TY  - BOOK
AU  - Heba Omar Ahmed Omar
AU  - Enas Ghareeb Elshazly , 
AU  - Iman Riad Abdelaal , 
AU  - Mohamed Ibrahem Sonbati , 
TI  - Effect of recombinant activated factor VII (rFVIIa) on intraoperative blood loss during pediatric brain surgery : : A clinical and thromboelastographic study / 
PY  - 2010///
CY  - Cairo : 
PB  - Heba Omar Ahmed Omar , 
KW  - Coagulopathy
KW  - Hemostasis
KW  - RFVIIa
N1  - Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Anaesthesia; Issued also as CD
N2  - There is a clinical need for one or more new hemostatic agents to supplement a help in controlling bleeding in pediatric brain tumor, which cannot be controlled by surgical intervention, local hemostatic agents and transfusion of blood products. Recombinant activated factor VII has been approved by the U.S Food and Drug Administration (FDA) for nearly a decade for the prevention and treatment of bleeding episodes in hemophilic patients with inhibitors to coagulation factor VIII or factor IX
UR  - http://172.23.153.220/th.pdf
ER  -